| 4BBX: reference: Discovery of a potent, selective and orally active PDE10A inhibitor for the potential treatment of schizophrenia., Bartolome-Nebreda JM, Delgado F, Martin ML, Martinez-Viturro CM, Pastor J, Tong HM, Iturrino L, Macdonald GJ, Sanderson WE, Megens A, Langlois X, Somers M, Vanhoof G, Conde Ceide S, J Med Chem. 2014 Apr 23. PMID: 24758746 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).